284 related articles for article (PubMed ID: 25713922)
41. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
42. Prognostic analysis of gastric signet ring cell carcinoma and mucinous carcinoma: a propensity score-matched study and competing risk analysis.
Tang CT; Chen Y; Zeng C
Aging (Albany NY); 2020 Nov; 12(21):22059-22077. PubMed ID: 33130635
[TBL] [Abstract][Full Text] [Related]
43. Comparison of Clinicopathological Features and Prognosis of Mucinous Gastric Carcinoma and other Gastric Cancers: A Retrospective Study of 4,417 Patients.
Ma Y; Zhang S; Wang Y; Hu C; Chen J; Pang C; Liang C; Yuan L; Du Y
J Gastrointest Surg; 2023 Nov; 27(11):2352-2364. PubMed ID: 37848685
[TBL] [Abstract][Full Text] [Related]
44. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients.
Wang JY; Hsieh JS; Huang CJ; Huang YS; Huang TJ
J Surg Oncol; 1996 Sep; 63(1):36-40. PubMed ID: 8841464
[TBL] [Abstract][Full Text] [Related]
45. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
46. BMI-adjusted prognosis of signet ring cell carcinoma in patients undergoing radical gastrectomy for gastric adenocarcinoma.
Wang JB; Lin MQ; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Zheng CH; Huang CM
Asian J Surg; 2021 Jan; 44(1):116-122. PubMed ID: 32467008
[TBL] [Abstract][Full Text] [Related]
47. Gallbladder metastasis secondary to gastric cancer as a first site of recurrence presented with acute cholecystitis: case report and literature review.
Bılıcı A; Şeker M; Öven Ustaalıoğlu BB; Keser SH; Cınaral F; Gümüş M
Turk J Gastroenterol; 2012; 23(6):764-8. PubMed ID: 23864451
[TBL] [Abstract][Full Text] [Related]
48. [Long-term outcome and analysis of prognostic factors in 114 cases of postoperative stage III gastric cancer].
Zhang Y; Ma LW
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):863-6. PubMed ID: 24447487
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of signet ring cell carcinoma of the stomach.
Kim JP; Kim SC; Yang HK
Surg Oncol; 1994 Aug; 3(4):221-7. PubMed ID: 7834113
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathologic study of early-stage mucinous gastric carcinoma.
Adachi Y; Yasuda K; Inomata M; Shiraishi N; Kitano S; Sugimachi K
Cancer; 2001 Feb; 91(4):698-703. PubMed ID: 11241236
[TBL] [Abstract][Full Text] [Related]
51. Lymph node dissection in resectable advanced gastric cancer.
de Steur WO; Dikken JL; Hartgrink HH
Dig Surg; 2013; 30(2):96-103. PubMed ID: 23867585
[TBL] [Abstract][Full Text] [Related]
52. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
[TBL] [Abstract][Full Text] [Related]
53. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathological and prognostic features of Borrmann type IV gastric cancer versus other Borrmann types: A unique role of signet ring cell carcinoma.
Liang C; Liang Y; Ou B; Yuan L; Yuan S
Saudi J Gastroenterol; 2023; 29(4):240-250. PubMed ID: 37470667
[TBL] [Abstract][Full Text] [Related]
55. Impact of histopathology on the outcome of D1/D2 gastrectomies with R0 resection.
Uslu A; Bati H; Postaci H; Nart A; Eliyatkin N; Yetis H; Corumlu B; Aykas A; Zengel B
Digestion; 2012; 86(1):67-73. PubMed ID: 22777320
[TBL] [Abstract][Full Text] [Related]
56. Lymphoepithelioma-like carcinoma of the stomach: a subset of gastric carcinoma with distinct clinicopathological features and high prevalence of Epstein-Barr virus infection.
Wang HH; Wu MS; Shun CT; Wang HP; Lin CC; Lin JT
Hepatogastroenterology; 1999; 46(26):1214-9. PubMed ID: 10370694
[TBL] [Abstract][Full Text] [Related]
57. Risk factors for lymph node metastasis in patients with early gastric cancer and signet ring cell histology.
Lee JH; Choi IJ; Kook MC; Nam BH; Kim YW; Ryu KW
Br J Surg; 2010 May; 97(5):732-6. PubMed ID: 20235088
[TBL] [Abstract][Full Text] [Related]
58. Signet ring cell carcinoma of the stomach: a clinicopathological comparison with the other histological types.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Kikuchi S; Yamauchi H
Tohoku J Exp Med; 1998 Oct; 186(2):121-30. PubMed ID: 10223615
[TBL] [Abstract][Full Text] [Related]
59. Clinicopathological features of signet-ring cell carcinoma of the colon and rectum: a case-matched study.
Min BS; Kim NK; Ko YT; Baek SH; Lee KY; Sohn SK; Cho CH; Kang DR
Hepatogastroenterology; 2009; 56(93):984-8. PubMed ID: 19760925
[TBL] [Abstract][Full Text] [Related]
60. Prognostic Impact of the Signet Ring Cell Type in Node-Negative Gastric Cancer.
Kong P; Wu R; Yang C; Geng Q; Liu J; Chen S; Liu X; Ye M; He W; Yang Q; Xia L; Xu D
Sci Rep; 2016 Jul; 6():26313. PubMed ID: 27381549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
